Aaron Cowen Suvretta Capital Management
Aaron Cowen is the founder of Suvretta Capital Management, a long/short equity firm with a fundamental research process. The firm invests across sectors with an emphasis on differentiated fundamental views. Cowen’s disclosures are tracked by investors who follow mid-to-large fundamental hedge funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$38M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
+$36.3M |
| 3 |
ETNB
89bio
ETNB
|
+$36.1M |
| 4 |
Bank of America
BAC
|
+$33.6M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$29.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$92M |
| 2 |
Coca-Cola
KO
|
+$48.2M |
| 3 |
Starbucks
SBUX
|
+$47M |
| 4 |
CRH
CRH
|
+$41.5M |
| 5 |
McDonald's
MCD
|
+$30M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 60.02% |
| 2 | Technology | 10.47% |
| 3 | Consumer Discretionary | 6.61% |
| 4 | Financials | 5.33% |
| 5 | Communication Services | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Oracle
ORCL
$422B
| $31.6M | 1.17% |
226,318
| – | – |
|
27
Tesla
TSLA
$1.43T
| $31.6M | 1.17% |
122,016
-41,614
| -25% | -$13.9M |
|
|
28
Bank of America
BAC
$431B
| $31.5M | 1.17% |
+753,913
| New | +$33.6M |
|
|
29
Coca-Cola
KO
$392B
| $29.8M | 1.1% |
415,720
-722,133
| -63% | -$48.2M |
|
|
30
Chipotle Mexican Grill
CMG
$46.7B
| $27.1M | 1.01% |
+539,540
| New | +$29.3M |
|
31
Mineralys Therapeutics
MLYS
$2.27B
| $26.5M | 0.98% |
+1,667,759
| New | +$19.2M |
|
32
Boston Scientific
BSX
$73B
| $26.4M | 0.98% |
262,099
-135,580
| -34% | -$13.7M |
|
33
United Airlines
UAL
$36.7B
| $25.3M | 0.94% |
366,375
+165,725
| +83% | +$15.7M |
|
34
Rocket Pharmaceuticals
RCKT
$385M
| $23.4M | 0.87% |
3,502,000
+935,049
| +36% | +$9.24M |
|
35
Ferguson
FERG
$46.9B
| $20.8M | 0.77% |
129,924
-115,606
| -47% | -$20M |
|
36
Snowflake
SNOW
$115B
| $20.2M | 0.75% |
+137,886
| New | +$23.4M |
|
37
Arcus Biosciences
RCUS
$3.86B
| $20.1M | 0.75% |
2,560,904
+1,984,748
| +344% | +$23M |
|
|
PVLA
38
Palvella Therapeutics
PVLA
$2.05B
| $20M | 0.74% |
714,463
| – | – |
|
39
Datadog
DDOG
$84.6B
| $18.2M | 0.67% |
183,231
+6,781
| +4% | +$856K |
|
40
Johnson & Johnson
JNJ
$651B
| $18.1M | 0.67% |
109,386
-30,600
| -22% | -$4.79M |
|
41
Abeona Therapeutics
ABEO
$348M
| $17.5M | 0.65% |
3,685,503
| – | – |
|
42
Erasca
ERAS
$6.17B
| $16.9M | 0.63% |
12,315,004
| – | – |
|
43
Biogen
BIIB
$32B
| $16.5M | 0.61% |
120,736
+5,300
| +5% | +$758K |
|
44
Caesars Entertainment
CZR
$6.06B
| $16.3M | 0.61% |
652,493
-119,919
| -16% | -$3.9M |
|
45
Aura Biosciences
AURA
$809M
| $16M | 0.59% |
+2,731,886
| New | +$20.7M |
|
46
UnitedHealth
UNH
$350B
| $15.7M | 0.58% |
29,900
-45,298
| -60% | -$23.2M |
|
47
Take-Two Interactive
TTWO
$44.8B
| $15M | 0.56% |
+72,400
| New | +$14.5M |
|
48
Moderna
MRNA
$57.9B
| $14.7M | 0.54% |
+517,163
| New | +$18.4M |
|
49
Fulcrum Therapeutics
FULC
$292M
| $14.6M | 0.54% |
5,067,394
+1,728,928
| +52% | +$6.35M |
|
50
Goldman Sachs
GS
$303B
| $14M | 0.52% |
25,538
-48,660
| -66% | -$29.3M |
|
Similar funds
Aaron Cowen's Q1 2025 Portfolio in Review
As of Q1 2025, Aaron Cowen held 112 positions worth $2.69B, down 8.2% from $2.93B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Aaron Cowen's Q1 2025 filing shows 16 new, 29 increased, 14 reduced and 12 closed positions. Its largest new stake was Home Depot: 97,571 shares worth $35.8M. The largest sale was Intra-Cellular Therapies Inc., an estimated $92M.
By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Technology and Consumer Discretionary.
- Aaron Cowen's largest Q1 2025 buy was Home Depot: 97,571 shares worth $35.8M.
- Aaron Cowen added most to Ultragenyx Pharmaceutical in Q1 2025, an estimated $36.3M increase.
- Aaron Cowen's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $92M.
- Aaron Cowen fully exited Starbucks in Q1 2025, selling an estimated $47M.
- Aaron Cowen's ten largest holdings make up 48% of its $2.69B portfolio in Q1 2025.
- Aaron Cowen opened 16 new positions and closed 12 in Q1 2025.
- Aaron Cowen's portfolio value fell 8.2% quarter-over-quarter to $2.69B.
Based on Suvretta Capital Management's 13F filing for Q1 2025, filed 15 May 2025.